Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using aminophylline to improve ureteral access for kidney stones

Official title: Efficacy of Intra-Ureteric Aminophylline Installation After Failed Stone Accessibility by Semi-rigid Ureteroscopy. Prospective Trial

Run by Al-Azhar University · NCT06728943 · Data updated 2026-11-12

This study is testing if using aminophylline can help people who have had trouble with kidney stone removal through a specific procedure to make it easier and safer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorAl-Azhar University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedDecember 1, 2024
Main results expectedDecember 1, 2028
Study endsDecember 1, 2028
Registry record updatedDecember 11, 2024
Trial IDNCT06728943 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients who have experienced failed stone accessibility by semi-rigid ureteroscopy.

Probably not a fit

Patients who are children, have contraindications to aminophylline, or have active urinary tract infections will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of local intraureteric aminophylline instillation in patients who have previously experienced failed access to ureteric stones via semi-rigid ureteroscopy. The approach aims to facilitate stone removal without the need for balloon dilation, potentially reducing complications associated with ureteroscopy. By relaxing smooth muscle and alleviating inflammation, aminophylline may enhance the success rate of ureteroscopic procedures. The study will include patients who meet specific criteria and will be conducted at Al-Azhar University in Cairo.

Why it matters

Potential benefit: If successful, this approach could improve the success rate of ureteroscopic procedures for patients with ureteric stones.

How similar studies have gone: While the use of aminophylline in this context is novel, similar studies have explored its effects in other urological applications, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The study will include patients with failed stone accessibility by semi-rigid ureteroscopy.

Exclusion Criteria:

* Child age group
* Pre stented patients
* Contraindications to aminophylline (hypersensitivity to drug components, pregnancy or lactation ,…)
* Contraindications to ureteroscopy (active urinary tract infection - Contraindications to general or spinal anesthesia - Uncorrected bleeding disorders)

Where it's running

  • Al-Azhar university, faculty of medicine, the urology department
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.